Polypeptide growth factors: their potential value in the management of breast cancer patients.
C K
CK
Osborne
D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000188:drug therapy*; D005260:Female; D006133:Growth Substances / Q000502:physiology*; D006801:Humans; D007334:Insulin-Like Growth Factor I / Q000494:pharmacology; D007335:Insulin-Like Growth Factor II / Q000494:pharmacology; D011379:Prognosis; D011956:Receptors, Cell Surface / Q000502:physiology; D017451:Receptors, Somatomedin; D016211:Transforming Growth Factor alpha / Q000032:analysis; D016212:Transforming Growth Factor beta / Q000494:pharmacology / Q000627:therapeutic use
D000911:Antibodies, Monoclonal; D006133:Growth Substances; D011956:Receptors, Cell Surface; D017451:Receptors, Somatomedin; D016211:Transforming Growth Factor alpha; D016212:Transforming Growth Factor beta; D007334:Insulin-Like Growth Factor I; D007335:Insulin-Like Growth Factor II